Who is sponsoring NCT05574894?

NCT05574894 is sponsored by ShangHai Ji Ai Genetics & IVF Institute.

What condition does NCT05574894 study?

NCT05574894 studies Growth Hormone, Advanced Maternal Age, PGT-A.

What drugs are being tested in NCT05574894?

Interventions: Growth hormone, GnRH antagonist.

What is the status of NCT05574894?

NCT05574894 is currently COMPLETED.

Last reviewed 2023-02-21 · How we verify

Effect of GH Supplementation on the Blastocyst Euploid Rate in AMA Patients--A Retrospective Cohort Study

NCT05574894 PHASE3 COMPLETED

This retrospective cohort study aims to investigate the effects of recombinant human growth hormone (rh-GH) on the euploid status of preimplantation blastocysts in AMA patients. Infertile patients aged 38-46 years old were recruited for study if they fulfill the inclusion criteria and do not have the exclusion criteria. Treatment group: Women received growth hormone (GH) supplement during antagonist protocol for ovarian stimulation. Control group: Women received antagonist protocol for ovarian stimulation. The primary outcome is the euploidy rate of blastocysts per stimulation cycle and per testing cycle.

Details

Lead sponsor	ShangHai Ji Ai Genetics & IVF Institute
Phase	PHASE3
Status	COMPLETED
Enrolment	692
Start date	Fri Jan 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Sep 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Growth Hormone
Advanced Maternal Age
PGT-A

Interventions

Growth hormone
GnRH antagonist

Countries

China